Letrozole (Femara) to Treat Breast Cancer | News - femora breast cancer


Letrozole (Femara) | Cancer information | Cancer Research UK femora breast cancer

Femara (chemical name: letrozole) is an aromatase inhibitor approved by the U.S. Food and Drug Administration (FDA) to treat.

Find out when letrozole (Femara) is prescribed, how it works and side effects. Letrozole is a hormone therapy and a type of aromatase inhibitor.

Like any drug, letrozole can cause side effects. Everyone reacts differently to drugs and some people have more side effects than others. Common side effects of.

In the Femara Study PO25, post-menopausal women with advanced breast cancer were randomized to receive letrozole 2.5 mg (n = 453) or.